Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SINTX Technologies

Explore full profile

Spinal and orthopedic implant company using its silicon nitride ceramic tech to develop spine and total joint implants

Salt Lake City, United StatesFounded 1996Biotech & Life Sciences
Valuation $9.5M Market cap · 2026
Revenue $3.0M Latest reported FY
Total funding $50–100M Disclosed equity funding

About SINTX Technologies

SINTX Technologies, Inc., based in Salt Lake City, UT, specializes in developing advanced ceramic materials for medical implants. Founded in 1996 by a material scientist and an orthopedic surgeon, the company initially focused on arthroplasty and later expanded into the spine market. SINTX's core product is silicon nitride, a ceramic material known for its strength, durability, and biocompatibility, making it ideal for use in the human body. The company serves medical device manufacturers and healthcare providers, operating primarily in the orthopedic and spine markets. SINTX generates revenue through the sale of its proprietary ceramic materials and licensing its technology to other medical device companies. The business model is centered on innovation, with a strong emphasis on research and development, as evidenced by its portfolio of 12 issued patents and 19 pending patents. SINTX's state-of-the-art manufacturing facility ensures high-quality production standards, further solidifying its position in the market. The company aims to enhance patient outcomes by providing superior implantable materials that reduce the risk of infection and improve the longevity of medical devices.

Source: Dealroom company data

At a glance

Founded
1996
Headquarters
Salt Lake City, United States
Listing
IPO 2014
Sector
Biotech & Life Sciences

Latest news

Press, funding announcements and product moves mentioning SINTX Technologies.

See all news

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • National Institutes of Health

Series B and later5 investors entered at this stage

  • Creation Capital
  • GE Capital
  • Hercules Capital
  • Magna
  • Crede CapitalGroup
Team profiled 28 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇮🇳 India2.6%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SINTX Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SINTX Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.